Form 8-K - Current report:
SEC Accession No. 0001079973-16-001190
Filing Date
2016-09-19
Accepted
2016-09-19 16:56:09
Documents
3
Period of Report
2016-09-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K appy_8k-091916.htm 8-K 19140
2 EXHIBIT 99.1 ex99x1.htm EX-99.1 19583
3 image00002.jpg GRAPHIC 2188
  Complete submission text file 0001079973-16-001190.txt   43126
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
Venaxis, Inc. (Filer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33675 | Film No.: 161892251
SIC: 2835 In Vitro & In Vivo Diagnostic Substances